ArticleCardiovascular diabetology2019

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob

Damilola D Adingupu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.